Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
ICLE 2022
2:08
Streamlining cell therapy manufacturing with CliniMACS Prodigy
Saskia Rösch
• 6 Apr 2022
1:28
Implementing automation technology in the CGT space
Saskia Rösch
• 6 Apr 2022
3:10
Utilizing flow cytometry in CAR T-cell research
Saskia Rösch
• 6 Apr 2022
1:13
PiggyBac Transposon-generated CAR T-cells in solid tumors
Shigeki Yagyu
• 8 Apr 2022
2:24
CAR T-cell therapy for neuroblastoma
Shigeki Yagyu
• 8 Apr 2022
4:06
Optimizing the upscaling and outscaling of CAR T-cell therapies
Saskia Rösch
• 6 Apr 2022
1:27
Direct detection and isolation of CAR cells from patient samples
Saskia Rösch
• 6 Apr 2022
5:56
Targeting neoantigens in multiple myeloma with CAR T-cell
Angela Krackhard
• 6 Apr 2022
2:30
Moving CAR T-cell therapies to earlier lines of therapy in multiple myeloma
Angela Krackhard
• 6 Apr 2022
1:22
Engineering NK cell-based cancer treatments
Juliane Mietz
• 1 Apr 2022
2:59
Photoporation with polydopamine nanosensitizers for mRNA delivery to T cells
Dominika Berdecka
• 1 Apr 2022
1:23
Enhancing the long-term functionality of CAR-T cells in solid tumors
Shigeki Yagyu
• 8 Apr 2022
2:37
The benefits of PiggyBac transposon-mediated CAR-T cell technology
Shigeki Yagyu
• 8 Apr 2022
4:27
Developing individualized cancer therapies with neoantigen-specific TCRs
Angela Krackhard
• 6 Apr 2022
5:33
Improving immune-imaging tools to assess cancer immunotherapies
Angela Krackhard
• 6 Apr 2022
3:25
An overview of mouse models to study cell therapies for cancer
Juliane Mietz
• 1 Apr 2022
1
2
3
Next